Cargando…
Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate
The mechanism of membrane fusion by “class II” viral fusion proteins follows a pathway that involves large-scale domain rearrangements of the envelope glycoprotein (E) and a transition from dimers to trimers. The rearrangement is believed to proceed by an outward rotation of the E ectodomain after l...
Autores principales: | Schmidt, Aaron G., Yang, Priscilla L., Harrison, Stephen C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851732/ https://www.ncbi.nlm.nih.gov/pubmed/20386713 http://dx.doi.org/10.1371/journal.ppat.1000851 |
Ejemplares similares
-
Small-Molecule Inhibitors of Dengue-Virus Entry
por: Schmidt, Aaron G., et al.
Publicado: (2012) -
Correction: Small-Molecule Inhibitors of Dengue-Virus Entry
por: Schmidt, Aaron G., et al.
Publicado: (2019) -
Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
por: De La Guardia, Carolina, et al.
Publicado: (2014) -
How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion
por: Chao, Luke H, et al.
Publicado: (2018) -
Crabohydrate-Related Inhibitors of Dengue Virus Entry
por: Hidari, Kazuya I.P.J., et al.
Publicado: (2013)